/ Investor Relations / Henry Schein Reports Third Quarter Diluted EPS from Continuing Operations of $0.41; Provides Updated 2005 EPS Guidance and Introduces Guidance Range for Fluvirin Vaccine Business Read more about Henry Schein Reports Third Quarter Diluted EPS from Continuing Operations of $0.41; Provides Updated 2005 EPS Guidance and Introduces Guidance Range for Fluvirin Vaccine Business Henry Schein to Webcast Third Quarter 2005 Conference Call Tuesday, October 25, at 10 A.M. ET Read more about Henry Schein to Webcast Third Quarter 2005 Conference Call Tuesday, October 25, at 10 A.M. ET Henry Schein Reports Second Quarter Results; Net Sales Increase 21% to $1.14 Billion Read more about Henry Schein Reports Second Quarter Results; Net Sales Increase 21% to $1.14 Billion Henry Schein to Webcast Second Quarter 2005 Conference Call Tuesday, July 26, at 10 A.M. ET Read more about Henry Schein to Webcast Second Quarter 2005 Conference Call Tuesday, July 26, at 10 A.M. ET Henry Schein Reports Record First Quarter Results; Net sales increase 24%; diluted EPS up 19% Read more about Henry Schein Reports Record First Quarter Results; Net sales increase 24%; diluted EPS up 19% Henry Schein to Webcast First Quarter 2005 Conference Call Tuesday, May 3, at 10 A.M. ET Read more about Henry Schein to Webcast First Quarter 2005 Conference Call Tuesday, May 3, at 10 A.M. ET Henry Schein Fourth Quarter Net Sales up 26% to $1.2 Billion; Diluted EPS of $0.33 After $0.10 Charge Related to Influenza Vaccine Contract Read more about Henry Schein Fourth Quarter Net Sales up 26% to $1.2 Billion; Diluted EPS of $0.33 After $0.10 Charge Related to Influenza Vaccine Contract Henry Schein to Webcast Fourth Quarter 2004 Conference Call Tuesday, March 1, at 10 A.M. ET Read more about Henry Schein to Webcast Fourth Quarter 2004 Conference Call Tuesday, March 1, at 10 A.M. ET Henry Schein Third Quarter Net Sales Top $1 Billion, up 16%; Company Introduces 2005 Diluted EPS Guidance Read more about Henry Schein Third Quarter Net Sales Top $1 Billion, up 16%; Company Introduces 2005 Diluted EPS Guidance Henry Schein to Webcast Third Quarter Conference Call Tuesday, October 26, at 10 a.m. ET Read more about Henry Schein to Webcast Third Quarter Conference Call Tuesday, October 26, at 10 a.m. ET Pagination First page « First Previous page ‹ Previous … Page 121 Page 122 Page 123 Page 124 Current page 125 Page 126 Page 127 Page 128 Page 129 … Next page Next › Last page Last » Subscribe to
Henry Schein Reports Third Quarter Diluted EPS from Continuing Operations of $0.41; Provides Updated 2005 EPS Guidance and Introduces Guidance Range for Fluvirin Vaccine Business Read more about Henry Schein Reports Third Quarter Diluted EPS from Continuing Operations of $0.41; Provides Updated 2005 EPS Guidance and Introduces Guidance Range for Fluvirin Vaccine Business
Henry Schein to Webcast Third Quarter 2005 Conference Call Tuesday, October 25, at 10 A.M. ET Read more about Henry Schein to Webcast Third Quarter 2005 Conference Call Tuesday, October 25, at 10 A.M. ET
Henry Schein Reports Second Quarter Results; Net Sales Increase 21% to $1.14 Billion Read more about Henry Schein Reports Second Quarter Results; Net Sales Increase 21% to $1.14 Billion
Henry Schein to Webcast Second Quarter 2005 Conference Call Tuesday, July 26, at 10 A.M. ET Read more about Henry Schein to Webcast Second Quarter 2005 Conference Call Tuesday, July 26, at 10 A.M. ET
Henry Schein Reports Record First Quarter Results; Net sales increase 24%; diluted EPS up 19% Read more about Henry Schein Reports Record First Quarter Results; Net sales increase 24%; diluted EPS up 19%
Henry Schein to Webcast First Quarter 2005 Conference Call Tuesday, May 3, at 10 A.M. ET Read more about Henry Schein to Webcast First Quarter 2005 Conference Call Tuesday, May 3, at 10 A.M. ET
Henry Schein Fourth Quarter Net Sales up 26% to $1.2 Billion; Diluted EPS of $0.33 After $0.10 Charge Related to Influenza Vaccine Contract Read more about Henry Schein Fourth Quarter Net Sales up 26% to $1.2 Billion; Diluted EPS of $0.33 After $0.10 Charge Related to Influenza Vaccine Contract
Henry Schein to Webcast Fourth Quarter 2004 Conference Call Tuesday, March 1, at 10 A.M. ET Read more about Henry Schein to Webcast Fourth Quarter 2004 Conference Call Tuesday, March 1, at 10 A.M. ET
Henry Schein Third Quarter Net Sales Top $1 Billion, up 16%; Company Introduces 2005 Diluted EPS Guidance Read more about Henry Schein Third Quarter Net Sales Top $1 Billion, up 16%; Company Introduces 2005 Diluted EPS Guidance
Henry Schein to Webcast Third Quarter Conference Call Tuesday, October 26, at 10 a.m. ET Read more about Henry Schein to Webcast Third Quarter Conference Call Tuesday, October 26, at 10 a.m. ET
